S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7131 +0.31%
PRE-MKT · 04:20 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

ROIV

Roivant Sciences Ltd.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
36.80
+1.88 +5.38%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $26.6BP/E —DIV YIELD —FCF YIELD -3.09%REV TTM $7.5M −67.6%NET INCOME −$266.3MNET CASH $936.7M52W 17.96 – 41.81NEXT EARNINGS Nov 9 EST.SEC XBRL · TTM TO Invalid Date

One year, everything drawn on

251 SESSIONS · DAILY CLOSES
44342516Oct 1 · Director sell $33KOct 1 · Director sell $608KSep 30 · President & Immunovant CEO sell $7.3MSep 15 · Director sell $16KSep 15 · Director sell $187KSep 15 · Director sell $24KSep 15 · Director sell $172KSep 8 · Director sell $798KAug 28 · President & Immunovant CEO sell $1.2MAug 28 · President & Immunovant CEO sell $5.9MAug 21 · President & CIO sell $5.3MAug 20 · President & CIO sell $653KAug 19 · President & CIO sell $6.4MAug 6 · 10-Q filed (Q1 2027)May 20 · 10-K filed (FY 2026)May 20 · 10-K filed (Q4 2026)Feb 6 · 10-Q filed (Q3 2026)Nov 10 · 10-Q filed (Q2 2026)Aug 6 · 10-Q filed (Q1 2026)May 20 · 10-K filed (FY 2025)May 20 · 10-K filed (Q4 2025)Feb 6 · 10-Q filed (Q3 2025)Nov 10 · 10-Q filed (Q2 2025)May 20 · 10-K filed (FY 2024)May 20 · 10-K filed (Q4 2024)OCT 2025JAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-22
Insiders (90d): $28.7M net selling
Shorts (latest report): 33.5M short · +2.9M last period
Every line of the math
27FLAG

Congress is trading it

No STOCK Act disclosure names ROIV.

Insider activity

ALL 13
DateInsiderTypeValue
Oct 1DirectorSell$33K
Oct 1DirectorSell$608K
Sep 30President & Immunovant CEOSell$7.3M
Sep 15DirectorSell$16K
Sep 15DirectorSell$187K
Sep 15DirectorSell$24K
Watch ROIV. Know when insiders buy.
One email the day a filing lands. Free.